. Author manuscript; available in PMC: 2014 Sep 19.

Published in final edited form as: Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006626. doi: 10.1002/14651858.CD006626.pub2

Analysis 2.1. Comparison 2 RISPERIDONE versus ARIPIPRAZOLE - all data short term, Outcome 1 Global state: 1a. No clinically significant response (as defined by the original studies).

Review: Risperidone versus other atypical antipsychotics for schizophrenia

Comparison: 2 RISPERIDONE versus ARIPIPRAZOLE - all data short term

Outcome: 1 Global state: 1a. No clinically significant response (as defined by the original studies)